On April 4, 2016, AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) announced positive interim financial results for the first quarter of 2016.  The company also announced positive interim results for its product candidates ARX-04, sufentanil sublingual tablet, 30 micrograms, and Zalviso.  The company also announced positive interim results in the first quarter of 2016 for ARX-04.  The company also announced positive interim results from a Phase 3 clinical trial for Zalviso.  The company's plans for Zalviso are being evaluated by the U.S. Department of Defense, the European Commission, and the U.K. Department of Health and Human Services.  The company's plans are being evaluated by the U.S. Market Abuse Unit, which is conducting a clinical trial of Zalviso in the U.S. and Europe.  The U.S. Market Abuse Unit is conducting an ongoing clinical trial of Zalviso.  The company is evaluating the safety and efficacy of the Zalviso sublingual tablet.  The company's plans are being reviewed by Ed Arce, Michael Higgins, and Hugo Ong of H.C. Wainwright & Co.  The SEC appreciates the assistance of the U.S. Department of Health and Human Services in this matter.  The SEC's Office of Investor Education and Advocacy has issued an Investor Alert on the subject of Zalviso.  The SEC encourages investors to check the backgrounds of people selling them investments by using the SEC's investor.gov website to quickly identify whether they are registered professionals.  The SEC's Office of Market Intelligence has also issued an Investor Alert on Zalviso.  The SEC's Office of Investor Education has issued an Investor Alert on Zalviso and related products.  The SEC encourages investors to check the background of anyone selling or offering them an investment using the SEC's investor.gov website.  The SEC's Office of Investor Education encourages investors to check the backgrounds of people selling or offering investments by using the SEC'sÂ Investor.govÂ to quickly identify whether they are registered professionals.Â  The SEC encourages investors to check the background of people selling or offering investments by using theÂ SEC'sÂ Investor.govÂ Investor.govÂ toÂ check the background of people selling or offering investments using theÂ Investor.govÂ feature.Â Investors canÂ check the background of anyone selling or offering investments using theÂ SECÂ Investor.govÂ 